Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study

NCT02401269 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Cardiovascular Disease Risk in HIV Patients
Endothelial Function

Interventions

DRUG: Aspirin
DRUG: Placebo

Sponsor

University of Pittsburgh

Collaborators

[object Object]
[object Object]